| Literature DB >> 31154693 |
Philip K Louie1, Andrew C Sexton1, Danel D Bohl1, Ehsan Tabaraee2, Steven M Presciutti3, Benjamin C Mayo4, Justin C Paul1, Comron Saifi5, Howard S An1.
Abstract
OBJECTIVE: To determine the risk factors associated with radiographic changes and clinical outcomes following 3-level anterior cervical discectomy and fusion (ACDF) using rigidplate constructs and cortico-cancellous allograft. ACDF has demonstrated efficacy for treatment of multilevel degenerative cervical conditions, but current data exists in small heterogeneous forms.Entities:
Keywords: Allograft; Bone plates; Spinal fusion
Year: 2019 PMID: 31154693 PMCID: PMC7136101 DOI: 10.14245/ns.1836052.026
Source DB: PubMed Journal: Neurospine ISSN: 2586-6591
Fig. 1.Lateral cervical spine radiographics obtained preoperatively (A), 2 weeks postoperatively (B), and the final follow-up (18 months) (C). Radiographic parameters measured include C2–7 lordosis, segmental angle (seg angle), C2–7 sagittal vertical axis (SVA), and segmental height (seg height).
Patient population (n=98)
| Variable | Value |
|---|---|
| Age (yr) | |
| 18–49 | 32 (32.7) |
| 50–59 | 35 (35.7) |
| ≥ 60 | 31 (31.6) |
| Current smoker | 13 (13.3) |
| Diabetes mellitus | 12 (12.2) |
| Levels | |
| C3–6 | 23 (23.5) |
| C4–7 | 71 (72.5) |
| C5–T1 | 4 (4.1) |
| Allograft | |
| Yes | 98 (100.0) |
| Graft type | |
| Biologic | 98 (100.0) |
| Fusion | 95 (96.9) |
| Body mass index (kg/m2) | 29.3 ± 7.2 |
| Charleston Comorbidity Index | 2.29 ± 2.29 |
| Operative time (min) | 150 ± 32 |
| Estimated blood loss (mL) | 111 ± 130 |
| Length of stay[ | 1.84 ± 0.88 |
Values are presented as number (%) or mean±standard deviation.
Days spent in the hospital following surgery.
Radiographic measurements and differences between radiographic measurements over time
| Variable | Radiographic measurements | Differences between radiographic measurements over time | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Preop. | Immediate postop. | Latest follow-up[ | Preop. to immediate postop. | Preop. to latest follow-up | Immediate postop. to latest follow-up | ||||
| Diff. | p-value[ | Diff. | p-value[ | Diff. | p-value[ | ||||
| Lordosis | 4.3 ± 9.9 | 10 ± 9.3 | 9.2 ± 8.6 | +5.5 | < 0.001[ | +5.0 | < 0.001[ | -0.5 | 0.211 |
| Sagittal vertical axis | 28.1 ± 12.2 | 31.3 ± 12 | 30.2 ± 11.5 | +3.2 | < 0.001[ | +1.7 | 0.042[ | -1.4 | 0.060 |
| Segmental angle | 0.3 ± 9.2 | 8.8 ± 6.8 | 7.4 ± 6.7 | +8.4 | < 0.001[ | +7.1 | < 0.001[ | -1.4 | 0.010[ |
| Segmental height | 70.7 ± 7.4 | 75.8 ± 7.4 | 74.1 ± 7.5 | +5.0 | < 0.001[ | +3.2 | < 0.001[ | -1.7 | < 0.001[ |
Values are presented as mean±standard deviation unless otherwise indicated.
Preop., preoperative.
p<0.05, statistically significant difference.
Wilcoxon matched-pairs signed-rank test.
Average follow-up: 24.3±13.7 months.
Incidence and risk factors for loss of lordosis of 5° or more from immediate postoperative to final follow-up
| Variable | Incidence (%) | Bivariate analyses | Multivariate analysis[ | ||||
|---|---|---|---|---|---|---|---|
| RR | 95% CI | p-value | RR | 95% CI | p-value | ||
| Overall | 23.5 | ||||||
| Age (yr) | 0.630 | > 0.05 | |||||
| 18–49 | 18.8 | Reference | NA | ||||
| 50–59 | 22.9 | 1.2 | 0.5–3.1 | ||||
| ≥ 60 | 29.0 | 1.5 | 0.6–3.9 | ||||
| Levels | < 0.001[ | < 0.001[ | |||||
| C3–6 | 21.7 | Reference | NA | ||||
| C4–7 | 21.1 | 1.0 | 0.4–2.4 | 1.0 | 0.4–2.4 | ||
| C5–T1 | 75.0 | 3.5 | 1.3–9.1 | 3.5 | 1.3–9.1 | ||
| Diabetes | > 0.05 | ||||||
| No | 19.7 | Reference | NA | ||||
| Yes | 25.0 | 1.1 | 0.4–2.7 | 0.491 | |||
| Current smoker | > 0.05 | ||||||
| No | 20.0 | Reference | NA | ||||
| Yes | 30.7 | 1.1 | 0.5–2.5 | 0.301 | |||
RR, relative risk; CI, confidence interval; NA, not applicable.
p<0.05, statistically significant difference.
The final multivariate model was selected through a backwards stepwise process in which all variables were initially included in the model and then the variables with the highest p-values were sequentially excluded from the model until only variables with p<0.05 remained.
Incidence and risk factors for gain of sagittal vertical axis of 5 mm or more from immediate postoperative to final follow-up
| Variable | Incidence (%) | Bivariate analyses | Multivariate analysis[ | ||||
|---|---|---|---|---|---|---|---|
| RR | 95% CI | p-value | RR | 95% CI | p-value | ||
| Overall | 15.3 | ||||||
| Age (yr) | 0.710 | > 0.05 | |||||
| 18–49 | 18.8 | Reference | NA | ||||
| 50–59 | 11.4 | 0.6 | 0.2–2.0 | ||||
| ≥ 60 | 16.1 | 0.9 | 0.3–2.5 | ||||
| Levels | 0.790 | > 0.05 | |||||
| C3–6 | 17.4 | Reference | NA | ||||
| C4–7 | 14.1 | 0.8 | 0.3–2.4 | ||||
| C5–T1 | 25.0 | 1.4 | 0.2–9.9 | ||||
| Plate type | 0.707 | > 0.05 | |||||
| Biomet | 21.7 | Reference | NA | ||||
| Depuy eagle | 11.6 | 0.5 | 0.2–1.7 | ||||
| Depuy sky | 12.5 | 0.6 | 0.1–2.6 | ||||
| Diabetes | > 0.05 | ||||||
| No | 13.9 | Reference | NA | ||||
| Yes | 25.0 | 1.2 | 0.4–3.1 | 0.301 | |||
| Current smoker | > 0.05 | ||||||
| No | 14.5 | Reference | NA | ||||
| Yes | 30.7 | 1.3 | 0.4–3.3 | 0.214 | |||
RR, relative risk; CI, confidence interval; NA, not applicable.
The final multivariate model was selected through a backwards stepwise process in which all variables were initially included in the model and then the variables with the highest p-values were sequentially excluded from the model until only variables with p<0.05 remained.
Incidence and risk factors for loss of segmental height of 2 mm or more from immediate postoperative to final follow-up
| Variable | Incidence (%) | Bivariate analysis | Multivariate analysis[ | ||||
|---|---|---|---|---|---|---|---|
| RR | 95% CI | p-value | RR | 95% CI | p-value | ||
| Overall | 40.8 | ||||||
| Age (yr) | 0.672 | > 0.05 | |||||
| 18–49 | 34.4 | Reference | NA | ||||
| 50–59 | 42.9 | 1.2 | 0.7–2.3 | ||||
| ≥ 60 | 45.2 | 1.3 | 0.7–2.4 | ||||
| Levels | 0.087 | > 0.05 | |||||
| C3–6 | 47.8 | Reference | NA | ||||
| C4–7 | 36.6 | 0.8 | 0.5–1.3 | ||||
| C5–T1 | 75.0 | 1.6 | 0.8–3.2 | ||||
| Plate type | 0.358 | > 0.05 | |||||
| Biomet | 39.1 | Reference | NA | ||||
| Depuy eagle | 46.5 | 1.2 | 0.6–2.2 | ||||
| Depuy sky | 18.8 | 0.5 | 0.2–1.5 | ||||
| Diabetes | > 0.05 | ||||||
| No | 38.4 | Reference | NA | ||||
| Yes | 41.7 | 1.1 | 0.6–2.4 | 0.424 | |||
| Current smoker | > 0.05 | ||||||
| No | 36.5 | Reference | NA | ||||
| Yes | 46.2 | 1.2 | 0.6–2.8 | 0.109 | |||
RR, relative risk; CI, confidence interval; NA, not applicable.
The final multivariate model was selected through a backwards stepwise process in which all variables were initially included in the model and then the variables with the highest p-values were sequentially excluded from the model until only variables with p<0.05 remained.
Incidence and risk factors for radiolucent lines around graft at final follow-up
| Variable | Incidence (%) | Bivariate analysis | Multivariate analysis[ | ||||
|---|---|---|---|---|---|---|---|
| RR | 95% CI | p-value | RR | 95% CI | p-value | ||
| Overall | 18.0 | ||||||
| Age | 0.023[ | 0.023[ | |||||
| 18–49 | 23.9 | Reference | Reference | ||||
| 50–59 | 9.8 | 0.5 | 0.3–1.2 | 0.5 | 0.2–1.0 | ||
| ≥ 60 | 6.5 | 0.3 | 0.1–0.9 | 0.3 | 0.1–0.9 | ||
| Levels | 0.946 | > 0.05 | |||||
| C3–6 | 17.1 | Reference | NA | ||||
| C4–7 | 18.6 | 1.0 | 0.4–2.0 | ||||
| C5–T1 | 19.2 | 1.1 | 0.3–5.1 | ||||
| Plate type | 0.175 | > 0.05 | |||||
| Biomet | 19.6 | Reference | NA | ||||
| Depuy eagle | 17.9 | 0.8 | 0.3–1.3 | ||||
| Depuy sky | 16.2 | 0.7 | 0.1–1.5 | ||||
| Diabetes | > 0.05 | ||||||
| No | 16.3 | Reference | NA | ||||
| Yes | 25.0 | 1.3 | 0.4–2.2 | 0.878 | |||
| Current Smoker | > 0.05 | ||||||
| No | 14.1 | Reference | NA | ||||
| Yes | 30.7 | 1.6 | 0.3–3.6 | 0.091 | |||
RR, relative risk; CI, confidence interval; NA, not applicable.
p<0.05, statistically significant difference.
The final multivariate model was selected through a backwards stepwise process in which all variables were initially included in the model and then the variables with the highest p-values were sequentially excluded from the model until only variables with p<0.05 remained.
Patient-reported outcomes following 3-level ACDF
| Variable | Preoperative | Postoperative | Difference | p-value[ |
|---|---|---|---|---|
| NDI | 52.3 ± 19.6 | 22.5 ± 24.2 | 29.8 ± 20.1 | < 0.001[ |
| VAS-neck score | 7.5 ± 3.3 | 2.2 ± 2.3 | 5.3 ± 3.7 | < 0.001[ |
| VAS-arm score | 5.3 ± 4.2 | 1.4 ± 2.5 | 3.9 ± 3.7 | < 0.001[ |
ACDF, anterior cervical discectomy and fusion; NSDI, Neck Disability Index; VAS, visual analogue scale.
p<0.05, statistically significant difference.
Paired t-tests.